Ensign Peak Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$131K Hold
8,990
﹤0.01% 1540
2026
Q1
$66.7K Hold
8,990
﹤0.01% 1652
2025
Q4
$106K Sell
8,990
-22,750
-72% -$245K ﹤0.01% 1559
2025
Q3
$245K Sell
31,740
-20,000
-39% -$140K ﹤0.01% 1616
2025
Q2
$378K Hold
51,740
﹤0.01% 1621
2025
Q1
$491K Hold
51,740
﹤0.01% 1558
2024
Q4
$853K Hold
51,740
﹤0.01% 1408
2024
Q3
$763K Hold
51,740
﹤0.01% 1464
2024
Q2
$718K Hold
51,740
﹤0.01% 1477
2024
Q1
$813K Sell
51,740
-2,610
-5% -$40.3K ﹤0.01% 1447
2023
Q4
$879K Buy
54,350
+19,250
+55% +$315K ﹤0.01% 1454
2023
Q3
$432K Hold
35,100
﹤0.01% 1628
2023
Q2
$564K Buy
+35,100
New +$578K ﹤0.01% 1603
2022
Q4
Sell
-38,580
Closed -$332K 2071
2022
Q3
$332K Sell
38,580
-890
-2% -$8.84K ﹤0.01% 1659
2022
Q2
$322K Hold
39,470
﹤0.01% 1648
2022
Q1
$480K Hold
39,470
﹤0.01% 1567
2021
Q4
$1.35M Sell
39,470
-63,530
-62% -$2.49M ﹤0.01% 1128
2021
Q3
$4.97M Hold
103,000
0.01% 665
2021
Q2
$4.65M Buy
103,000
+16,800
+19% +$744K 0.01% 681
2021
Q1
$4.16M Buy
86,200
+4,100
+5% +$213K 0.01% 707
2020
Q4
$4.42M Hold
82,100
0.01% 653
2020
Q3
$3.03M Hold
82,100
0.01% 776
2020
Q2
$2.54M Hold
82,100
0.01% 840
2020
Q1
$2.27M Buy
82,100
+1,300
+2% +$38.9K 0.01% 777
2019
Q4
$2.36M Buy
+80,800
New +$1.92M 0.01% 981

Other funds holding NEO

Ensign Peak Advisors's NEO Position: Q2 2026 in Review

Ensign Peak Advisors held its NeoGenomics (NEO) position steady in Q2 2026 at 8,990 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #1540.

Ensign Peak Advisors first reported a position in NEO in Q4 2019 and has held it in 25 quarters since. The position peaked at $4.97M in Q3 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Ensign Peak Advisors held 8,990 shares of NeoGenomics worth $131K as of Q2 2026.
  • Ensign Peak Advisors left its NeoGenomics share count unchanged in Q2 2026.
  • NeoGenomics made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1540 holding.
  • Ensign Peak Advisors first reported a position in NeoGenomics in Q4 2019 and has held it in 25 quarters since.
  • Ensign Peak Advisors's NeoGenomics position peaked at $4.97M in Q3 2021.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.